Previous 10 | Next 10 |
ENGLEWOOD, CO / ACCESSWIRE / April 23, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced the signing of a definitive agreement (the "Agreement") with Singa...
Aytu BioScience, Inc. (AYTU) COVID-19 Initiatives Update Call April 21, 2020 4:30 PM ET Company Participants Josh Disbrow - Chairman and Chief Executive Officer Conference Call Participants Presentation Operator Good Afternoon and thank you for joining us today for the ...
April 22, 2020 Palm Beach, FL – April 22, 2020 – Scientists around the world are trying to go where no man has gone before… to develop a vaccine in less than 12-18 months… much less. The pressure is great but the collaboration s unprecedented. Anthony F...
Nasally-Administered Natesto Testosterone Replacement Therapy Increases Serum Testosterone, Improves Hypogonadal Symptoms While Simultaneously Preserving Semen Parameters and Gonadotropin Hormones ENGLEWOOD, CO / ACCESSWIRE / April 21, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "C...
I believe companies that have recently announced gigantic operational pivots into Coronavirus responses are good candidates for sale or short sale. One such company is Aytu BioSciences ( AYTU ), a very active Coronavirus announcer with a suspect historical product portfolio and a head-spinning...
Are These The Best Penny Stocks To Buy Right Now? After another week of exuberance, broader sector stocks have pulled back on Monday. But that hasn’t stopped certain penny stocks from soaring. In fact, this week we’re already seeing big moves being made by a select list of penny ...
Avalon GloboCare (NASDAQ: AVCO ) +44% on advancing immunotherapeutic program towards combatting cytokine storm associated with COVID-19 lung damage and mortality. More news on: Avalon GloboCare Corp., Eros International Plc, VBI Vaccines Inc., Stocks on the move, , Read more ....
Cedars-Sinai-Developed ‘Healight' Medical Device Platform Technology Being Studied as a Potential First-in-Class COVID-19 Treatment Conference Call Scheduled for Tuesday, April 21, 2020 at 4:30 pm ET ENGLEWOOD, CO / ACCESSWIRE / April 20, 2020 / Aytu BioScience, Inc. (NASDAQ...
BOSTON, April 17, 2020 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a national securities litigation firm, is investigating Aytu BioScience, Inc. (NASDAQ: AYTU) and certain of its officers for potential securities fraud. Investors who purchased Aytu shares sho...
Chinese Officials Confirm China Won't Restrict Exports of Medical Products Needed to Fight Coronavirus Company in Late-Stage Negotiations to Secure Distribution Agreement for Additional COVID-19 IgG/IgM Rapid Test Which is Approved by China's National Medical Products Administration (NM...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...